CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis

The objective of this study was to evaluate the predictive role of CD21low B cells as markers of new digital ulcers in systemic sclerosis patients. Peripheral blood B cell subpopulations and clinical assessments have been evaluated in 74 systemic sclerosis patients at baseline and after a 12‐month follow‐up. After a 12‐month follow‐up, 23 (31.1%) systemic sclerosis patients developed new digital ulcers. The median percentage of CD21low B cells was significantly higher in patients with than without new digital ulcers [10.1 (4.3–13.6) versus 4.8 (3.5–7.4); p < 0.01]. The 10% cut‐off shows good diagnostic accuracy [area under the curve (AUC) = 0.732, confidence interval (CI) = 0.587–0.878; P = 0.01]. Kaplan–Meier curves show a significantly reduced free survival from new digital ulcers in systemic sclerosis patients with CD21low B cells ≥ 10% (p < 0.0001). In multivariate analysis, CD21low B cells ≥ 10%, modified Rodnan skin score (mRSS) and systolic pulmonary arterial pressure (sPAP) are associated with the development of new digital ulcers. We hypothesize that CD21low B cells are a predictive marker of new digital ulcers in systemic sclerosis patients.

[1]  A. Gigante,et al.  CD21low B cells in systemic sclerosis: A possible marker of vascular complications. , 2020, Clinical immunology.

[2]  Satish Patel,et al.  Scleroderma: An insight into causes, pathogenesis and treatment strategies. , 2019, Pathophysiology : the official journal of the International Society for Pathophysiology.

[3]  M. Boubaya,et al.  Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study , 2019, Annals of the rheumatic diseases.

[4]  P. Vermersch,et al.  Altered B lymphocyte homeostasis and functions in systemic sclerosis. , 2018, Autoimmunity reviews.

[5]  A. Manfredi,et al.  Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. , 2017, Autoimmunity reviews.

[6]  Oliver Distler,et al.  Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis , 2017, Journal of scleroderma and related disorders.

[7]  M. Baron,et al.  The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index , 2016, Annals of the rheumatic diseases.

[8]  L. Czirják,et al.  Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis. , 2016, Clinical and experimental rheumatology.

[9]  A. Biere,et al.  Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation , 2015, Front. Immunol..

[10]  U. Müller-Ladner,et al.  An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. , 2015, Clinical and experimental rheumatology.

[11]  R. Cianci,et al.  Increased Intrarenal Arterial Stiffness May Predict the Occurrence of New Digital Ulcers in Systemic Sclerosis , 2014, Arthritis care & research.

[12]  M. Richard,et al.  Ischemic Digital Ulcers Affect Hand Disability and Pain in Systemic Sclerosis , 2014, Journal of Rheumatology.

[13]  C. Bonroy,et al.  Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study , 2012, Annals of the rheumatic diseases.

[14]  D. Conforti,et al.  Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. , 2010, Rheumatology.

[15]  E. Hachulla,et al.  Clinical Features of Scleroderma Patients With or Without Prior or Current Ischemic Digital Ulcers: Post-Hoc Analysis of a Nationwide Multicenter Cohort (ItinérAIR-Sclérodermie) , 2009, The Journal of Rheumatology.

[16]  R. D'amico,et al.  Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. , 2009, Arthritis and rheumatism.

[17]  E. Hachulla,et al.  Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. , 2007, The Journal of rheumatology.

[18]  S Paolino,et al.  Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? , 2006, Rheumatology.

[19]  A. Silman,et al.  A disease severity scale for systemic sclerosis: development and testing. , 1999, The Journal of rheumatology.

[20]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[21]  V. Prus.  [Digital ulcers in systemic sclerosis]. , 2010, Reumatizam.